SCHEMBL11113380

SCHEMBL11113380

O=C1CCCCCC1CCCCCO

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.45
CA1 P00915 3/20 0.44
CA2 P00918 3/20 0.44
CA4 P22748 3/20 0.44
CA6 P23280 2/20 0.44
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
GAA P10253 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
LMNA P02545 1/20 0.41
KMT2A Q03164 2/20 0.38
HLCS P50747 1/20 0.36
PTGS1 P23219 3/20 0.36
PTGS2 P35354 3/20 0.36
OPRK1 P41145 1/20 0.36
HTT P42858 1/20 0.36
EPHX1 P07099 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3834144 1.00 KDM4E (0.45) KDM4ECA1CA2CA4CA6
SCHEMBL3818006 0.98 KDM4E (0.46) KDM4ECA1CA2CA4CA6
SCHEMBL7911743 0.98 KDM4E (0.46) KDM4ECA1CA2CA4CA6
SCHEMBL11107701 0.94 NPC1 (0.44) KDM4ECA1CA2CA4CA6
SCHEMBL3817854 0.93 KDM4E (0.47) KDM4ECA1CA2CA4CA6
SCHEMBL11595453 0.91 KDM4E (0.49) KDM4ECA1CA2CA4CA6
SCHEMBL11058566 0.87 KDM4E (0.50) KDM4ECA1CA2CA4CA6
SCHEMBL3819009 0.85 KDM4E (0.50) KDM4ECA1CA2CA4CA6
Hydrogen Peroxide SCHEMBL28783701 0.83 NPC1 (0.47) KDM4ECA1CA2CA4CA6
SCHEMBL2221778 0.83 KDM4E (0.51) KDM4ECA1CA2CA4CA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0107733-A4 CYCLOALIPHATIC PHARMACEUTICAL COMPOUNDS. CBD CORP (US) 1984-09-13 EP disclosed
EP-0107733-A1 CYCLOALIPHATIC PHARMACEUTICAL COMPOUNDS. CBD CORP (US) 1984-05-09 EP disclosed
WO-1983004019-A1 CYCLOALIPHATIC PHARMACEUTICAL COMPOUNDS CBD CORPORATION (US) 1983-11-24 WO disclosed